Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Jiangsu Hengrui Pharmaceuticals
Pharma
Lilly, Pfizer-Sciwind, Astellas—Fierce Pharma Asia
Lilly made a trio of investments in East Asia. Pfizer partner Sciwind got an obesity nod in China. MFN appears to have helped Astellas in Japan.
Angus Liu
Mar 13, 2026 8:05am
Kyowa, Sino Biopharm, Duality—Fierce Pharma Asia
Mar 6, 2026 9:35am
Lilly-Innovent, AstraZeneca, Madrigal—Fierce Pharma Asia
Feb 13, 2026 8:25am
AZ, Boehringer-Simcere, Daiichi and more—Fierce Pharma Asia
Jan 30, 2026 7:45am
Celltrion buy, Rexulti CRL, Glenmark-Hengrui—Fierce Pharma Asia
Sep 26, 2025 10:00am
Glenmark, Hengrui ink $1.1B deal for HER2 ADC
Sep 24, 2025 10:16am
